Asset sale Completed
Telix Pharmaceuticals acquisition of ImaginAb therapeutic candidates, biologics technology platform and research facility
US$45m consideration
Announced 31 Jan 2025
Advisers
- Target
- ImaginAb therapeutic candidates, biologics technology platform and research facility
- Acquirer
- Telix Pharmaceuticals
- Seller
- ImaginAb
- Completed
- 31 Jan 2025
- Sector
- Biotech and pharmaceuticals
In the league tables
Similar deals
- Animalcare Group acquisition of Randlab Group Dec 2024 · A$120m · Biotech and pharmaceuticals
- TPG acquisition of Agilex Biolabs Sep 2026 · A$160m · Biotech and pharmaceuticals
- Avista Healthcare Partners acquisition of Mayne Pharma Group Feb 2025 · A$672m · Biotech and pharmaceuticals
- BDT & MSD Partners stake in DBG Health Aug 2025 · A$1.6bn · Biotech and pharmaceuticals
- BGH Capital acquisition of Aspen Pharmacare Asia Pacific business Jun 2026 · A$2.4bn · Biotech and pharmaceuticals
Sources
- 31 Jan 2025 Telix Completes Acquisition of Tx Assets, Biologics Platform ASX